Astrocytoma malignant

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Phase III: 1 Phase I (First in Human): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi Academic
    VORASIDENIB
    2024-519404-27-00 8 countries 2026 n=247 Orphan
    Recruiting

Phase I (First in Human)

1 trial
  • Curevac AG Commercial
    IMP not specified
    2022-501423-25-00 3 countries 2023 n=54
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Curevac AG Commercial 1 Phase I (First in Human) 0
Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi Academic 1 Phase III 1
New trials by year
2023
1
2026
1
← All indication landscapes